Electroacupuncture at Zusanli (ST 36) for treatment of nausea and vomiting caused by the chemotherapy of the malignant tumor: a multicentral randomized controlled trial.
- Author:
Yan YANG
1
;
Yue ZHANG
;
Nian-cai JING
;
Yi LU
;
Hong-yu XIAO
;
Guang-li XU
;
Xiu-ge WANG
;
Li-ming WANG
;
Ya-ming ZHANG
;
Dong-jiao ZHANG
;
Qi-liang DUAN
Author Information
- Publication Type:Journal Article
- MeSH: Acupuncture Points; Adolescent; Adult; Aged; Antineoplastic Agents; adverse effects; Electroacupuncture; Female; Humans; Male; Middle Aged; Nausea; etiology; therapy; Neoplasms; complications; drug therapy; pathology; Vomiting; etiology; therapy; Young Adult
- From: Chinese Acupuncture & Moxibustion 2009;29(12):955-958
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo compare the clinical effects between electroacupuncture at Zusanli (ST 36) combined with intravenous drip of Granisetron and intravenous drip of Granisetron only for treatment of nausea and vomiting caused by the chemotherapy of the malignant tumor.
METHODSThe methods of multicentral, randomized controlled trial were used, the observation group (127 cases) was treated with electroacupuncture at Zusanli (ST 36) combined with intravenous drip of Granisetron, and the control group (119 cases) was treated with intravenous drip of Granisetron only.
RESULTSThe total effective rate of 90.5% in observation group was superior to that of 84.0% in control group (P < 0.01); the nausea and vomiting scores of two groups were obviously decreased after treatment (both P < 0.001), and the decreased degree of the observation group was superior to that of control group (P < 0.001).
CONCLUSIONElectroacupuncture at Zusanli (ST 36) can significantly alleviate the symptoms such as nausea and vomiting caused by the chemotherapy of the patients.
